Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity

A. G. L. S. D. Silva, D. M. Laks, C. B. Magalhaes, P. P. Pereira-Junior, J. H. M. Nascimento, A. P. C. Davel, L. V. Rossoni, C. M. Takiya, D. S. Faffe, W. A. Zin (Rio de Janeiro, São Paulo, Brazil)

Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Session: Experimental approaches in animals and modelling in humans
Session type: E-Communication Session
Number: 4727

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. G. L. S. D. Silva, D. M. Laks, C. B. Magalhaes, P. P. Pereira-Junior, J. H. M. Nascimento, A. P. C. Davel, L. V. Rossoni, C. M. Takiya, D. S. Faffe, W. A. Zin (Rio de Janeiro, São Paulo, Brazil). Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity. Eur Respir J 2009; 34: Suppl. 53, 4727

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009


Rosiglitazone, an agonist of PPARγ, reduces acute lung injury in endotoxemic rats
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005

Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Clenbuterol antagonize the effect of chronic administration of steroid respiratory muscle in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 496s
Year: 2002

Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017



Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008

Theophylline increases muscle sympathetic activity in patients with congestive heart failure
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003


Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Paraquat-induced lung injury in rat presents altered pressor chemoreflex response probably due to vascular dysfunction
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Hyperinflation associated with COPD is associated with impaired cardiac function and spontaneous baroreceptor sensitivity
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007


Creatine supplementation attenuates systemic and pulmonary effects of acute lung injury induced by pulmonary ischemia-reperfusion in rats
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


The hsp90 inhibitor, 17-AAG prevents and reverses the increases in lung calcineurin expression and activity associated with monocrotaline-induced right ventricular hypertrophy
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010

Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 334s
Year: 2004

The PPAR-β/δ agonist GW0742 reverses right venticular hypertrophy in a chronically hypoxic rat model of pulmonary hypertension
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010


Aminophylline increases respiratory muscle activity during hypercapnia in humans
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008

Dexamethasone reduces lung inflammation induced by alveolar stretch in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011

α1-adrenoceptor antagonism does not modify the pulmonary vasoconstrictor effect of dexfenfluramine in the rat
Source: Eur Respir J 2001; 18: Suppl. 33, 491s
Year: 2001

Improvement of exercise capacity due to beta blocker treatment in the model of MCT induced pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008